Search

Your search keyword '"Caccamo, Gaia"' showing total 32 results
Start Over Author "Caccamo, Gaia"
32 results on '"Caccamo, Gaia"'

7. Hypergammaglobulinemia before Starting DAA Therapy Is A Strong Predictor of Disease Progression in Cirrhotic Patients Even after HCV Clearance

Author

Franzè, Maria Stella, primary, Filomia, Roberto, additional, Caccamo, Gaia, additional, Pitrone, Concetta, additional, Alibrandi, Angela, additional, Saitta, Carlo, additional, Caspanello, Amalia Rita, additional, Asero, Clelia, additional, Arcadi, Vittoria, additional, Raimondo, Giovanni, additional, and Cacciola, Irene, additional

Published
2022
Full Text
View/download PDF

10. Atrial fibrillation in patients with cirrhosis

Author

Mwalitsa, Jean P., Maimone, Sergio, Filomia, Roberto, Alibrandi, Angela, Saitta, Carlo, Caccamo, Gaia, Cacciola, Irene, Spinella, Rosaria, Oliva, Giovanni, Lembo, Tindaro, Vadalà, Domenica, Gambino, Giuseppe, Raimondo, Giovanni, and Squadrito, Giovanni

Published
2016
Full Text
View/download PDF

13. Cirrhotic Patients with Bacterial Infection and Negative Cultures Have a More Advanced Disease and an Increased Short-Term Mortality Rate

Author

Caccamo, Gaia, primary, Franzè, Maria Stella, additional, Saffioti, Francesca, additional, Pitrone, Concetta, additional, Porcari, Serena, additional, Alibrandi, Angela, additional, Filomia, Roberto, additional, Mondello, Placido, additional, Cacciola, Irene, additional, Saitta, Carlo, additional, Squadrito, Giovanni, additional, Raimondo, Giovanni, additional, and Maimone, Sergio, additional

Published
2021
Full Text
View/download PDF

14. Over time evaluation of glycaemic control in direct‐acting antiviral‐treated hepatitis C virus/diabetic individuals with chronic hepatitis or with cirrhosis

Author

Cacciola, Irene, primary, Russo, Giuseppina, additional, Filomia, Roberto, additional, Pitrone, Concetta, additional, Caccamo, Gaia, additional, Giandalia, Annalisa, additional, Alibrandi, Angela, additional, Stella Franzè, Maria, additional, Porcari, Serena, additional, Maimone, Sergio, additional, Saitta, Carlo, additional, Squadrito, Giovanni, additional, and Raimondo, Giovanni, additional

Published
2021
Full Text
View/download PDF

16. Randomised study comparing 48 and 96 weeks peginterferon α-2a therapy in genotype D HBeAg-negative chronic hepatitis B

Author

Lampertico, Pietro, Viganò, Mauro, Di Costanzo, Giovan Giuseppe, Sagnelli, Evangelista, Fasano, Massimo, Di Marco, Vito, Boninsegna, Sara, Farci, Patrizia, Fargion, Silvia, Giuberti, Tiziana, Iannacone, Claudio, Regep, Loredana, Massetto, Benedetta, Facchetti, Floriana, Colombo, Massimo, Andreone, Pietro, Riili, Anna, Scuteri, Alessandra, Cursaro, Carmela, Andriulli, Angelo, Anna Niro, Grazia, Angarano, Gioacchino, Fasano, Massimo, Santantonio, Teresa Antonia, Palattella, Maria Stefania, Brunetto, Maurizia, Colombatto, Piero, Coco, Barbara, Ciccorossi, Pietro, Oliveri, Filippo, Sacco, Rodolfo, Bruno, Savino, Bollani, Simona, Chiesa, Alberto, Carosi, Giampiero, Baiguera, Chiara, Rossi, Stefania, Zaltron, Serena, Puoti, Massimo, Colombo, Massimo, Lampertico, Pietro, Cozzolongo, Raffaele, Giannuzzi, Vito, Craxì, Antonio, Di Marco, Vito, Calvaruso, Vincenza, Venezia, Giovanna, Di Costanzo, Giovan Giuseppe, Lanza, Alfonso Galeota, Di Perri, Giovanni, Cariti, Giuseppe, Mollaretti, Oscar, De Blasi, Tiziano, Kulmiye, Cumar, Rostagno, Roberto, Farci, Patrizia, Eliana Lai, Maria, Serra, Giancarlo, Chessa, Luchino, Balestrieri, Cinzia, Cauli, Cristiana, Fargion, Silvia Rossana, Bertelli, Cristina, Fatta, Erika, Fattovich, Giovanna, Pasino, Michela, Zanni, Silvia, Olivari, Nicola, Zagni, Irene, Ferrari, Carlo, Schivazappa, Simona, Giuberti, Tiziana, Laccabue, Diletta, Penna, Amalia, Gaeta, Giovanbattista, Stanzione, Maria, Stornaiuolo, Gianfranca, Martines, Diego, Boninsegna, Sara, Raimondo, Giovanni, Caccamo, Gaia, Squadrito, Giovanni, Isgrò, Graziella, Rizzetto, Mario, Lagget, Marco, Carenzi, Silvia, Ruggiero, Giuseppe, Marrone, Aldo, Sagnelli, Evangelista, Messina, Vincenzo, Ulisse Di Caprio, Domenico Umberto, Selva, Vincenzo, and Toniutto, Pierluigi

Published
2013
Full Text
View/download PDF

17. Rate of hepatocellular carcinoma diagnosis in cirrhotic patients with ultrasound-detected liver nodules

Author

Franzè, Maria Stella, primary, Bottari, Antonio, additional, Caloggero, Simona, additional, Pitrone, Alessia, additional, Barbera, Adalberto, additional, Lembo, Tindaro, additional, Caccamo, Gaia, additional, Cacciola, Irene, additional, Maimone, Sergio, additional, Alibrandi, Angela, additional, Pitrone, Concetta, additional, Squadrito, Giovanni, additional, Raimondo, Giovanni, additional, and Saitta, Carlo, additional

Published
2020
Full Text
View/download PDF

22. Hypergammaglobulinemia is a strong predictor of disease progression, hepatocellular carcinoma, and death in patients with compensated cirrhosis

Author

Cacciola, Irene, primary, Filomia, Roberto, additional, Alibrandi, Angela, additional, Franzè, Maria Stella, additional, Caccamo, Gaia, additional, Maimone, Sergio, additional, Saitta, Carlo, additional, Saffioti, Francesca, additional, Squadrito, Giovanni, additional, and Raimondo, Giovanni, additional

Published
2018
Full Text
View/download PDF

25. Acute hepatitis C: A 24-week course of pegylated interferon alpha-2b versus a 12-week course of pegylated interferon alpha-2b alone or with ribavirin

Author

Santantonio, Teresa, Fasano, Massimo, Sagnelli, Evangelista, Tundo, Paolo, Babudieri, Sergio, Fabris, Paolo, Toti, Mario, Di Perri, Giovanni, Marino, Nicoletta, Pizzigallo, Eligio, Angarano, Gioacchino, Pastore, Giuseppe, Guastadisegni, Angela, Volpe, Anna, Stano, Francesca, Tommasi, Donato, Maci, Annamaria, Resta, Francesco, Loperfido, Pietro, Esposito, Roberto, Borghi, Vanni, Fontana, Tommaso, Francavilla, Ruggiero, Mazzola, Michele, Pipoli, Antonella, Stanzione, Marinella, Amoroso, Pietro, Lettieri, Gennaro, Messina, Vincenzo, Antonucci, Giorgio, Rosati, Silvia, Giacometti, Andrea, Costa, Chiara, De Stefano, Carlo Biagio, Cariti, Giuseppe, Tositti, Giulia, Piera Riccardi, M., Verucchi, Gabriella, Francisci, Daniela, Petrelli, Enzo, Stoppini, Laura, Raimondo, Giovanni, Squadrito, Giovanni, Caccamo, Gaia, Antonino, Picciotto, Basso, Monica, Lazzarin, Adriano, Morsica, Giulia, Mian, Peter, Pristerà, Raffael, Teresa Santantonio, Massimo Fasano, Evangelista Sagnelli, Paolo Tundo, Sergio Babudieri, Paolo Fabri, Mario Toti, Giovanni Di Perri, Nicoletta Marino, Eligio Pizzigallo, Gioacchino Angarano, the Acute Hepatitis C Study Group: [.., Gabriella Verucchi, and ]

Subjects
Adult, Male, medicine.medical_specialty, CLEARANCE, Combination therapy, Adolescent, MONOTHERAPY, VIRUS-INFECTION, Gastroenterology, Antiviral Agents, law.invention, Medication Adherence, Polyethylene Glycols, ALPHA-INTERFERON, chemistry.chemical_compound, Young Adult, Pharmacotherapy, Randomized controlled trial, Drug Therapy, law, Multicenter trial, Internal medicine, Ribavirin, medicine, Clinical endpoint, Humans, Hepatology, business.industry, Interferon-alpha, Middle Aged, Hepatitis C, Recombinant Proteins, Surgery, Acute Disease, Drug Therapy, Combination, Female, Treatment Outcome, Clinical trial, chemistry, Combination, business
Abstract

Therapy of acute hepatitis C (AHC) has not yet been standardized and several issues are still unresolved. This open, randomized, multicenter trial aimed to assess the efficacy and safety of a 24-week course of pegylated IFN (Peg-IFN) alpha-2b versus a 12-week course of Peg-IFN alpha-2b alone or with ribavirin (RBV) in AHC patients. One hundred and thirty HCV acutely infected patients who did not spontaneously resolve by week 12 after onset were consecutively enrolled and randomized to receive Peg-IFN alpha-2b monotherapy (1.5 μg/kg/week) for 24 or 12 weeks (arm 1, n = 44 and arm 2, n = 43, respectively) or in combination with RBV (10.6 mg/kg/day) for 12 weeks (arm 3, n = 43). The primary endpoint was undetectable HCV RNA at 6-month posttreatment follow-up (sustained virological response; SVR). All patients were followed for 48 weeks after therapy cessation. HCV RNA levels were determined by real-time polymerase chain reaction (limit of detection: 15 IU/mL) at the central laboratory at baseline, week 4, end of treatment, and 6 and 12 months posttreatment. Using an intent-to-treat analysis, overall SVR rate was 71.5%. In particular, an SVR was achieved in 31 of 44 (70.5%), 31 of 43 (72.1%), and 31 of 43 (72.1%) patients in arms 1, 2, and 3, respectively (P = 0.898). Sixteen patients (12.3%) prematurely discontinued therapy or were lost to follow-up; thus, sustained response rates with per-protocol analysis were 81.6%, 81.6%, and 81.6% for patients in arms 1, 2, and 3 respectively. With multivariate analysis, virologic response at week 4 of treatment was an independent predictor of SVR. Peg-IFN alpha-2b was well tolerated. Conclusion: Peg-IFN alpha-2b induces a high SVR in chronically evolving AHC patients. Response rates were not influenced by combination therapy or treatment duration. © 2014 by the American Association for the Study of Liver Diseases.

Published
2014

26. Atrial fibrillation in patients with cirrhosis

Author

Mwalitsa, Jean P., primary, Maimone, Sergio, additional, Filomia, Roberto, additional, Alibrandi, Angela, additional, Saitta, Carlo, additional, Caccamo, Gaia, additional, Cacciola, Irene, additional, Spinella, Rosaria, additional, Oliva, Giovanni, additional, Lembo, Tindaro, additional, Vadalà, Domenica, additional, Gambino, Giuseppe, additional, Raimondo, Giovanni, additional, and Squadrito, Giovanni, additional

Published
2015
Full Text
View/download PDF

27. SP211ACUTE KIDNEY INJURY IN CIRRHOTIC PATIENTS UNDERGOING CONTRAST-ENHANCED COMPUTED TOMOGRAPHY

Author

Visconti, Luca, primary, Filomia, Roberto, additional, Maimone, Sergio, additional, Montuori, Francesca, additional, Ricciardi, Carlo Alberto, additional, Di Mauro, Eleonora, additional, Saitta, Carlo, additional, Cacciola, Irene, additional, Caccamo, Gaia, additional, Aloisi, Carmela, additional, Santoro, Domenico, additional, Squadrito, Giovanni, additional, Raimondo, Giovanni, additional, and Buemi, Michele, additional

Published
2015
Full Text
View/download PDF

28. Is there a downgrading in the alert about the hepatitis B virus infection in Italy?

Author

Raimondo, Giovanni, Isgrò, G, Caccamo, Gaia, Pollicino, Teresa, Squadrito, Giovanni, and Calabrian HBV Study Group

Subjects
Adult, Male, Heterozygote, HBsAg, Adolescent, viruses, HBV, anti-HBV vaccination, co-infections, POPULATION-BASED SURVEY, HEPATOCELLULAR-CARCINOMA, medicine.disease_cause, Chronic liver disease, Virus, Liver disease, Patient Education as Topic, Antigen, medicine, Humans, Practice Patterns, Physicians', Aged, Aged, 80 and over, Hepatitis B virus, Hepatitis B Surface Antigens, Hepatology, medicine.diagnostic_test, business.industry, Gastroenterology, Middle Aged, Hepatitis B, medicine.disease, Virology, Vaccination, Italy, Liver biopsy, Immunology, Female, business
Abstract

Background and aim There is suspicion of a decrease in warning regarding the hepatitis B virus as a health problem both by the infected individuals and their doctors. The aim of this study was to investigate whether the clinical/virology investigation of chronic hepatitis B virus infected individuals is at present accurate. Methods The chronic hepatitis B virus surface antigen carriers consecutively attending 13 different hospital divisions in Calabria from July to December 2005 were evaluated to investigate the available information on the grade of their liver disease, their virologic profile and the hepatitis B virus status of their family members. Results Four-hundred-thirty hepatitis B virus surface antigen positive individuals were enrolled, 417 of whom were Calabrians. Most of them had a diagnosis of chronic liver disease, but a liver biopsy had been performed only in 13.5% of the cases, whereas more than 1/3 of them had not been tested for hepatitis Delta virus co-infection. The majority of these individuals were unaware of the hepatitis B virus status of their family members. Moreover, anti-hepatitis B virus vaccination procedures were not performed in most of the hepatitis B virus surface antigen carrier families. Conclusions This study revealed that fundamental clinical, virological, and epidemiological aspects of chronic hepatitis B virus infection are not investigated in many hepatitis B virus surface antigen carriers, suggesting that the general knowledge as regards hepatitis B virus is mostly inadequate.

Published
2007

31. Occult HBV infection

Author

Raimondo, Giovanni, primary, Caccamo, Gaia, additional, Filomia, Roberto, additional, and Pollicino, Teresa, additional

Published
2012
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results